Importation Debate Highlights Need For Lower Rx Prices, McClellan Says
Executive Summary
The debate over drug importation highlights the need for reduced drug prices, Centers for Medicare & Medicaid Services Administrator Mark McClellan said Aug. 30
You may also be interested in...
House May Be Stopping Point For Rx Importation Bills, Hill Staffer Says
The House could be the last line of defense for blocking prescription drug importation legislation, rather than the Senate, a House subcommittee staffer said Nov. 17 at the Pharmaceutical Regulatory & Compliance Congress in Washington, D.C
House May Be Stopping Point For Rx Importation Bills, Hill Staffer Says
The House could be the last line of defense for blocking prescription drug importation legislation, rather than the Senate, a House subcommittee staffer said Nov. 17 at the Pharmaceutical Regulatory & Compliance Congress in Washington, D.C
Reimportation Can Be Stopped, Sen. Santorum Says
President Bush is not articulating opposition to price controls when discussing pharmaceutical importation on the campaign trail due to the difficulty of conveying that message to voters, Sen. Rick Santorum (R-Penn.) said in an Oct. 28 interview with "The Pink Sheet.